Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Wortman BG, Creutzberg CL, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LCHW, van der Steen-Banasik EM, Mens JWM, Slot A, Kroese MCS, van Triest B, Nijman HW, Stelloo E, Bosse T, de Boer SM, van Putten WLJ, Smit VTHBM, Nout RA; PORTEC Study Group.
Injectable recombinant human collagen-derived material with high cell adhesion activity limits adverse remodelling and improves pelvic floor function in pelvic floor dysfunction rats.
Li H, You S, Yang X, Liu S, Hu L.
Biomater Adv. 2022 Mar;134:112715. doi: 10.1016/j.msec.2022.112715. Epub 2022 Feb 12.
PMID:35599098
Cochrane Review Summaries-October 2020.
O'Mathuna D, Berghella V, Bellussi F, Kumar N, Haas DM.
Clinical adhesion score (CLAS): development of a novel clinical score for adhesion-related complications in abdominal and pelvic surgery.
Lier EJ, van den Beukel BAW, Gawria L, van der Wees PJ, van den Hil L, Bouvy ND, Cheong Y, de Wilde RL; CLAS Collaboration; van Goor H, Stommel MWJ, Ten Broek RPG.
Surg Endosc. 2021 May;35(5):2159-2168. doi: 10.1007/s00464-020-07621-5. Epub 2020 May 14.